Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC53H72N8O13S |
InChIKeyPEZCAXDTKNFUCR-CTMFSBKBSA-N |
CAS Registry2358775-70-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United Kingdom | 15 Jun 2019 |